New Developments in Metastatic Breast Cancer: Applying Today’s Optimal Care
Join expert faculty, Mohammad Jahanzeb, MD, Joyce O’Shaughnessy, MD, and Lee Schwartzberg, MD, FACP, to hear their insights on applying new data, FDA approvals, and NCCN Guideline recommendations on metastatic breast cancer to clinical practice. This unique symposium is designed to provide an entertaining and collegial setting that promotes peer-to-faculty interactions through the use of an interactive quiz game format.
This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.
Following this program, participants should be able to:
- Select the most appropriate agents consistent with current treatment guidelines for treating patients with metastatic breast cancer
- Apply current NCCN guidelines regarding prognostic and predictive markers to better select therapies for patients with metastatic breast cancer
- Incorporate recent clinical trial data to help balance the adverse event risk and efficacy benefit when selecting treatments for individual patients with metastatic breast cancer
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician